| Literature DB >> 30666854 |
Masanori Takabayashi1,2, Hassaan Majeed2, Andre Kajdacsy-Balla3, Gabriel Popescu2,2.
Abstract
We propose an intrinsic cancer marker in fixed tissue biopsy slides, which is based on the local spatial autocorrelation length obtained from quantitative phase images. The spatial autocorrelation length in a small region of the tissue phase image is sensitive to the nanoscale cellular morphological alterations and can hence inform on carcinogenesis. Therefore, this metric can potentially be used as an intrinsic cancer marker in histopathology. Typically, these correlation length maps are calculated by computing two-dimensional Fourier transforms over image subregions-requiring long computational times. We propose a more time-efficient method of computing the correlation map and demonstrate its value for diagnosis of benign and malignant breast tissues. Our methodology is based on highly sensitive quantitative phase imaging data obtained by spatial light interference microscopy.Entities:
Keywords: biopsy slide diagnosis; breast cancer; quantitative phase imaging
Mesh:
Substances:
Year: 2019 PMID: 30666854 PMCID: PMC6985696 DOI: 10.1117/1.JBO.24.1.016502
Source DB: PubMed Journal: J Biomed Opt ISSN: 1083-3668 Impact factor: 3.170
Fig. 1SLIM system. (a) Optical setup. (b) Phase patterns displayed on LCPM and corresponding intensity patterns captured by CCD. (c) Example of quantitative phase images of benign and malignant breast tissue cores and their expanded views.
Fig. 2Definition of local 2-D function .
Fig. 3Example of local spatial autocorrelation length maps. (a) Quantitative phase images, (b) the local correlation length maps, and (c) the local correlation length maps after applying the mask removing .
Fig. 4Local spatial autocorrelation length of benign () and grade 1 (), grade 2 (), and grade 3 () tissues.
The -values between different grades.
| Grades to be evaluated | |
|---|---|
| Benign—Malignant (G1, G2, G3) | 0.000876 |
| Benign and Malignant (G1)—Malignant (G2, G3) | 0.000335 |
| Benign—Malignant (G1) | 0.101101 |
| Benign—Malignant (G2) | 0.005891 |
| Benign—Malignant (G3) | 0.000498 |
| Malignant (G1)—Malignant (G2) | 0.193509 |
| Malignant (G1)—Malignant (G3) | 0.018837 |
| Malignant (G2)—Malignant (G3) | 0.417581 |